Cargando…
Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapy
PURPOSE: To test the efficacy of the intravitreal dexamethasone (DEX) implant in patients with retinal vein occlusions (RVOs) who have failed multiple anti-vascular endothelial growth factor (anti-VEGF) treatments. METHODS: A randomized exploratory study of ten patients with branch RVO or central RV...
Autores principales: | Wallsh, Josh, Sharareh, Behnam, Gallemore, Ron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888726/ https://www.ncbi.nlm.nih.gov/pubmed/27307697 http://dx.doi.org/10.2147/OPTH.S105412 |
Ejemplares similares
-
Anti-VEGF-Resistant Retinal Diseases: A Review of the Latest Treatment Options
por: Wallsh, Josh O., et al.
Publicado: (2021) -
Initial Ten Years of Experience with the Intravitreal Dexamethasone Implant: A Retrospective Chart Review
por: Wallsh, Josh, et al.
Publicado: (2020) -
Dexamethasone implant in retinal vein occlusions
por: Han, Sang Beom, et al.
Publicado: (2016) -
Switch of Intravitreal Therapy for Macular Edema Secondary to Retinal Vein Occlusion from Anti-VEGF to Dexamethasone Implant and Vice Versa
por: Pielen, Amelie, et al.
Publicado: (2017) -
Real-life study of the use of anti-VEGF therapy versus dexamethasone implant for treatment of macular edema in retinal vein occlusion
por: de Salles, Manuel Casselholm, et al.
Publicado: (2021)